PCRX vs PFE: Which Stock is Better?
Side-by-side comparison of Pacira BioSciences, Inc. and Pfizer Inc in 2026
PCRX
Pacira BioSciences, Inc.
—
PFE
Pfizer Inc
$23.72
Key Metrics Comparison
| Metric | PCRX | PFE | Winner |
|---|---|---|---|
| Market Cap | $890.84M | $147.73B | PFE |
| P/E Ratio | 174.15 | 19.79 | PFE |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PCRX
Full quant analysis
Analyze PFE
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PCRX or PFE a better investment?
Comparing PCRX and PFE: Pacira BioSciences, Inc. has a market cap of $890.84M while Pfizer Inc has $147.73B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PCRX and PFE?
PCRX (Pacira BioSciences, Inc.) and PFE (Pfizer Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PCRX or PFE?
Based on P/E ratios, PFE trades at a lower multiple (19.8x vs 174.2x).
Which is growing faster: PCRX or PFE?
Both PCRX and PFE show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PCRX or PFE?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PCRX or PFE?
Pfizer Inc (PFE) is larger with a market cap of $147.73B compared to $890.84M for PCRX.
Should I buy PCRX or PFE in 2026?
Both PCRX and PFE have investment merit. PCRX trades at $N/A while PFE trades at $23.72. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PCRX and PFE stock?
Key differences: Market Cap ($890.84M vs $147.73B), P/E Ratio (174.2x vs 19.8x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PCRX or PFE in 2026?
The choice between PCRX and PFE depends on your investment goals. PFE shows higher revenue growth (0.0%). PFE has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PCRX and PFE?
PCRX (Pacira BioSciences, Inc.) has a market cap of $890.84M, while PFE (Pfizer Inc) has a market cap of $147.73B. PFE is the larger company by market value.